Familial breast cancer: Is it time to move from a reactive to a proactive role?

Familial Cancer

Volumn 10, Issue 3, 2011, Pages 501-503

  Harris, H ^b   Nippert, I ^d   Julian Reynier, C ^c   Schmidtke, J ^e   Van Asperen, C ^f   Gadzicki, D ^e   Tibben, A ^f,g   Evans, D G ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c AIX MARSEILLE UNIVERSITY   (France)

^d INST OF REPRO MED OF THE UNIV   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

BRCA1; BRCA2; Breast cancer; Mortality; Proactive; Screening

Indexed keywords

BREAST CANCER; CANCER RISK; CONFERENCE PAPER; EVIDENCE BASED MEDICINE; FAMILIAL CANCER; FRANCE; GENERAL PRACTITIONER; GENETIC RISK; GERMANY; HEALTH PERSONNEL ATTITUDE; HUMAN; NETHERLANDS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; SURGEON; UNITED KINGDOM;

BREAST NEOPLASMS; FAMILY PRACTICE; FEMALE; HUMANS; QUESTIONNAIRES; RISK ASSESSMENT;

EID: 80055015141     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-011-9434-1     Document Type: Conference Paper

References (9)

1. VR Grann JS Jacobson D Thomason, et al. 2002 Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis J Clin Oncol 20 10 2520 2529 12011131 10.1200/JCO.2002.10.101 (Pubitemid 34525739)
2. MS van Roosmalen LC Verhoef PF Stalmeier, et al. 2002 Decision analysis of prophylactic surgery or screening for BRCA1 mutation carriers: a more prominent role for oophorectomy J Clin Oncol 20 8 2092 2100 11956270 10.1200/JCO.2002.08.035 (Pubitemid 34408800)
3. McIntosh A, Shaw C, Evans G, et al. (2004 updated 2006) Clinical guidelines and evidence review for the classification and care of women at risk of familial breast cancer. National Collaborating Centre for Primary Care/University of Sheffield, London. NICE guideline CG041. www.nice.org.uk
4. MO Leach CR Boggis AK Dixon, et al. 2005 Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) Lancet 365 9473 1769 1778 15910949 10.1016/S0140-6736(05)66481-1 1:STN:280: DC%2BD2M3mvFCqtg%3D%3D (Pubitemid 40744657)
5. M Kriege CT Brekelmans C Boetes, et al. 2004 Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition N Engl J Med 351 5 427 437 15282350 10.1056/NEJMoa031759 1:CAS:528:DC%2BD2cXmtFalu7o%3D (Pubitemid 38988592)
6. DGR Evans AD Baildam E Anderson, et al. 2009 Risk reducing mastectomy: outcomes in 10 European Centres J Med Genet 46 4 254 258 18996907 10.1136/jmg.2008.062232 1:STN:280:DC%2BD1M3msFSktw%3D%3D
7. SM Domchek TM Friebel-Klingner SL Neuhausen, et al. 2006 Mortality reduction after risk-reducing bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers Lancet Oncol 7 3 223 229 16510331 10.1016/S1470-2045(06) 70585-X 1:CAS:528:DC%2BD28XitVeitLs%3D (Pubitemid 43286452)
8. SM Domchek TM Friebel CF Singer, et al. 2010 Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality JAMA 304 9 967 975 20810374 10.1001/jama.2010.1237 1:CAS:528:DC%2BC3cXhtFWjsbrF
9. FH01 Management Committee, Steering Committee, Collaborators 2010 Tumour attributes and implications for future mortality in the FH01 study of mammographic surveillance in women aged 40-49 with a family history of breast cancer Lancet Oncol 11 12 1127 1134 10.1016/S1470-2045(10)70263-1